Free Trial

TerrAscend Q1 2024 Earnings Report

TerrAscend logo
$0.46 -0.02 (-3.97%)
As of 04/1/2025 03:54 PM Eastern

TerrAscend EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.03
Beat/Miss
Missed by -$0.03
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$80.63 million
Expected Revenue
$81.44 million
Beat/Miss
Missed by -$810.00 thousand
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Remove Ads

TerrAscend Earnings Headlines

Critical Review: TerrAscend (TSNDF) & The Competition
Head to Head Comparison: TerrAscend (TSNDF) & Its Peers
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Analyzing TerrAscend (TSNDF) and Its Competitors
Head to Head Survey: TerrAscend (TSNDF) & The Competition
TerrAscend (TSNDF) & Its Competitors Head-To-Head Analysis
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat